Catalyst Wire Dossier Catalyst Wire Dossier

Malaria vaccine 257049

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Malaria vaccine 257049, covering 2013-05-27 to 2019-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa [Phase 3]

See pricing